首页 | 本学科首页   官方微博 | 高级检索  
     


CD47: a new target in cardiovascular therapy
Authors:Isenberg Jeff S  Roberts David D  Frazier William A
Affiliation:Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:CD47, originally named integrin-associated protein, is a receptor for thrombospondin-1. A number of important roles for CD47 have been defined in regulating the migration, proliferation, and survival of vascular cells, and in regulation of innate and adaptive immunity. The recent discovery that thrombospondin-1 acts via CD47 to inhibit nitric oxide signaling throughout the vascular system has given new importance and perhaps a unifying mechanism of action to these enigmatic proteins. Here we trace the development of this exciting new paradigm for CD47 function in vascular physiology.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号